Notícias

While recent literature has shown the efficacy of the SARS-CoV-2 vaccine in preventing infection, it’s impact on need for emergency...

A FACTO n° 66 aborda o tema inovação. Em sua Matéria Política, destaca as
dificuldades estruturais do Brasil na...

There are limited data on the effectiveness of the vaccines against symptomatic coronavirus disease 2019 (Covid-19) currently authorized in the...

The lack of effective treatment options to reduce COVID-19 associated mortality, disease progression, and the need for invasive mechanical ventilation...

ABIFINA em encontro da indústria brasileira com a vice-diretora-geral da Organização
Mundial do Comércio (OMC)

Corona Virus Disease 2019 (COVID-19), referred to as ‘New Coronary Pneumonia’, is a type of acute infectious disease caused by...

Antibodies are made by the body as a defence against disease. However, they can also be produced in a laboratory...

The coronavirus disease 2019 has infected over 150 million people worldwide and led to over 3 million deaths. Severe acute...

The novel coronavirus SARS-CoV-2 since its emergence at Wuhan, China in December 2019 has been creating global health turmoil despite...

Farmanguinhos/Fiocruz realiza Chamada Pública Nº 011/2021 para seleção de
empresas para formalização de parceria para a transferência de tecnologia...

The aim of the study is to study the utility of various inflammatory markers in predicting outcomes of hospitalized patients...

Severe coronavirus disease-2019 (COVID-19) can progress to an acute respiratory distress syndrome (ARDS), which involves alveolar infiltration by activated neutrophils....